Moderna MRNA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Contract with Customer, Liability by Product | ||||||
| Net product sales | $95M-11.2% | $107M-25.7% | $144M-34.8% | $221M+43.5% | $154M-18.1% | |
| Other revenue | $161M+11.0% | $145M-17.6% | $176M+184% | $62M+114% | $29M+26.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Moderna break its business down?
- Moderna (MRNA) reports contract with customer, liability by product across 2 parts — Net product sales and Other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Moderna's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Moderna's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
